Public health and hepatitis C

Canadian Journal of Public Health

Volumn 91, Issue SUPPL. 1, 2000, Pages

  Patrick, D M ^a   Buxton, J A ^a   Bigham, M ^a   Mathias, R G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CD4 ANTIGEN; GLYCOPROTEIN; HEPATITIS A VACCINE; HEPATITIS B VACCINE; HEPATITIS C ANTIBODY; HEPATITIS C VACCINE; IMMUNOGLOBULIN D; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VIRUS ENVELOPE PROTEIN; VIRUS RNA;

ARTICLE; BREAST MILK; CANADA; CONTROLLED STUDY; EPIDEMIC; EPIDEMIOLOGICAL DATA; HEALTH BEHAVIOR; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH SURVEY; HEPATITIS C; HUMAN; INCIDENCE; INFECTION CONTROL; INTRAVENOUS DRUG ABUSE; LEGAL ASPECT; PREVALENCE; PRIMARY PREVENTION; PUBLIC HEALTH; REVIEW; SOCIAL CONTROL; TOBACCO; VACCINATION; VIRUS TRANSMISSION;

CANADA; COMMUNICABLE DISEASE CONTROL; DRUG AND NARCOTIC CONTROL; HEPATITIS C; HUMANS; POPULATION SURVEILLANCE; PRIMARY PREVENTION; PUBLIC POLICY; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0033767720     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Hepatitis C - Prevention and control: A public health consensus
2. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease
3. Estimating the number of blood transfusion recipients infected by hepatitis C virus in Canada, 1960-1985 and 1990-1992
4. The prevalence of hepatitis C in a community based population, Ontario, 1996
5. Preventing the transmission of blood-borne pathogens in health care and public service settings
6. Detection of HCV RNA in saliva, urine, seminal fluid and ascites
7. Hepatitis C virus RNA in saliva of patients with posttransfusion hepatitis and low efficiency of transmission among spouses
8. Mother-to-infant transmission of hepatitis C virus and breast-feeding
9. Mother-to-infant transmission of hepatitis C virus
10. Risk factors for mother-to-child transmission of HIV-1
11. Epidemiology of hepatitis C virus infection among injection drug users in Australia
12. Hepatitis C prevalence and incidence in Vancouver IDUs
13. Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency and human T-lymphotropic viruses
14. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
15. Hepatitis C virus infection in the United States
16. Incidence/window period model
17. Mother-to-infant transmission of hepatitis C virus
18. Mother-to-infant transmission of hepatitis C virus
19. Hepatitis C in children
20. A review of hepatitis C virus (HCV) vertical transmission: Risk of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection
21. Mother to child transmission of hepatitis C virus: Prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1
22. Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers
23. Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers
24. Hepatitis C-role of perinatal transmission
25. Spread of hepatitis C virus infection within families. Investigators of an Italian multicenter group
26. Hepatitis C virus infection in the family setting
27. Hepatitis C virus infection in households of anti-HCV chronic carriers in Italy: A multicentre case-control study
28. Intrafamily transmission of hepatitis C virus: Sexual and non-sexual contacts
29. Intraffamilial transmission of hepatitis C virus in hemodialysis patients
30. HCV transmission in family members of subjects with HCV related chronic liver disease
31. Lack of transmission of hepatitis C in household contacts of children with homozygous betathalassaemia
32. Sexual and perinatal transmission of hepatitis C
33. Heterosexual transmission of hepatitis C virus among married couples in southwestern Japan
34. Intrafamiliar transmission of hepatitis C virus among the population of an endemic area of Japan
35. Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin
36. Interspousal and interfamilial transmission of hepatitis C virus: A myth or a concern?
37. Hepatitis C virus infection in spouses of patients with type C chronic liver disease
38. Prevalence of hepatitis C virus infection in the household contacts of patients with HCV-related chronic liver disease
39. Hepatitis C virus transmitted by a tattooing needle
40. Risk of hepatitis C virus infection from tattoing and other skin piercing services
41. Fulminant hepatitis associated with hepatitis A virus super-infection in patients with chronic hepatitis C
42. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NSI proteins and the pestivirus envelope glycoproteins
43. Characterization of hypervariable regions in the putative envelope protein of hepatitis C virus
44. Marked sequence diversity in the putative envelope proteins of hepatitis C viruses
45. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: Potential role in chronic HCV infections
46. Association between MHC class II alleles and clearance of circulating hepatitis C virus
47. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia
48. Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection
49. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response
50. Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity
51. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection
52. Vaccination of chimpanzees against infection by the hepatitis C virus
53. Effect of immune globulin on the prevention of experimental hepatitis C virus infection
54. Prevalence, incidence and risk factors of Hepatitis C virus infection among drug users in Amsterdam
55. Hepatitis C virus infection among Alaskan drug users
56. Hepatitis virus infection and liver disease in injecting drug users who died suddenly
57. Human immunodeficiency virus seroprevalence and risk behaviours in patients attending sexually transmitted disease clinics in Alberta
58. Prevalence and incidence of Hepatitis C virus infection among young adult injection drug users
59. Hepatitis C: Prevention, counselling and medical evaluation
60. Drugs of abuse and the brain
61. Drug legalization, harm reduction, and drug policy
62. Legalization of drugs of abuse and the pediatrician
63. Pharmacology of the drugs of abuse and the development of public policy